GENESCO ($GCO) posted quarterly earnings results for Q1 2027 on Friday, May 29th. The company reported earnings of -$2.18 per share, beating estimates of -$2.59 by $0.41. The company also reported revenue of $487,030,000, beating estimates of $479,745,455 by $7,284,545.
You can see Quiver Quantitative's $GCO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
GENESCO Hedge Fund Activity
We have seen 64 institutional investors add shares of GENESCO stock to their portfolio, and 75 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FUND 1 INVESTMENTS, LLC removed 560,931 shares (-56.9%) from their portfolio in Q1 2026, for an estimated $16,261,389
- KINGDON CAPITAL MANAGEMENT, L.L.C. added 244,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $7,073,560
- NOMURA HOLDINGS INC removed 232,682 shares (-59.3%) from their portfolio in Q1 2026, for an estimated $6,745,451
- PZENA INVESTMENT MANAGEMENT LLC removed 163,114 shares (-13.1%) from their portfolio in Q1 2026, for an estimated $4,728,674
- JPMORGAN CHASE & CO removed 162,811 shares (-97.4%) from their portfolio in Q4 2025, for an estimated $4,032,828
- JACOBS LEVY EQUITY MANAGEMENT, INC added 151,923 shares (+236.6%) to their portfolio in Q1 2026, for an estimated $4,404,247
- MARSHALL WACE, LLP removed 122,922 shares (-70.6%) from their portfolio in Q1 2026, for an estimated $3,563,508
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
